Christopher Stevo | Head of Investor Relations |
Ludwig Hantson | Chief Executive Officer |
Aradhana Sarin | Chief Financial Officer |
John Orloff | Global Head of R&D |
Brian Goff | Chief Commercial and Global Operations Officer |
Josh Schimmer | Evercore ISI |
Cory Kasimov | JPMorgan |
Geoffrey Porges | SVB Leerink |
Christopher Raymond | Piper Sandler |
Philip Nadeau | Cowen & Company |
Geoff Meacham | Bank of America |
Ladies and gentlemen, thank you for standing by, and welcome to the Alexion Pharmaceuticals’ Second Quarter 2020 Conference Call. At this time, all participant lines are in a listen-only telephone. Please be advised that today's conference maybe recorded. [Operator instructions] I would like to hand the conference over to your speaker today Mr. Chris Stevo, Head of Investor Relations.